Panache Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.60 M
- Revenue Growth 7.49%
- Profit Growth 72.17%
- Ebitda 91.42%
- Net Worth -19.21%
- Total Assets 88.62%
About Panache Life Sciences
Panache Life Sciences Private Limited (PLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 2010 and has a history of 14 years and ten months. Its registered office is in Lucknow, Uttar Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shachindra Srivastava and Shalini Srivastava serve as directors at the Company.
Company Details
- Location Lucknow, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74992UP2010PTC040143
- Company No.
040143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2010
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Panache Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shachindra Srivastava  | Director | 07-Apr-2010 | Current |
| Shalini Srivastava | Director | 20-Feb-2015 | Current |
Financial Performance of Panache Life Sciences.
Panache Life Sciences Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 7.49% increase. The company also saw a substantial improvement in profitability, with a 72.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panache Life Sciences?
In 2017, Panache Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.60 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2012 | State Bank Of India | ₹0.60 M | Satisfied |
How Many Employees Work at Panache Life Sciences?
Unlock and access historical data on people associated with Panache Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panache Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panache Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
